JP2018533557A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018533557A5 JP2018533557A5 JP2018517626A JP2018517626A JP2018533557A5 JP 2018533557 A5 JP2018533557 A5 JP 2018533557A5 JP 2018517626 A JP2018517626 A JP 2018517626A JP 2018517626 A JP2018517626 A JP 2018517626A JP 2018533557 A5 JP2018533557 A5 JP 2018533557A5
- Authority
- JP
- Japan
- Prior art keywords
- antagonist
- group
- calcitonin
- antibody
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562237624P | 2015-10-06 | 2015-10-06 | |
| US62/237,624 | 2015-10-06 | ||
| PCT/US2016/055502 WO2017062456A2 (en) | 2015-10-06 | 2016-10-05 | Biomarkers related to interleukin-33 (il-33)-mediated diseases and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018533557A JP2018533557A (ja) | 2018-11-15 |
| JP2018533557A5 true JP2018533557A5 (https=) | 2019-11-14 |
| JP6858182B2 JP6858182B2 (ja) | 2021-04-14 |
Family
ID=57223756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018517626A Active JP6858182B2 (ja) | 2015-10-06 | 2016-10-05 | インターロイキン３３（ｉｌ−３３）媒介疾患に関するバイオマーカーおよびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10005834B2 (https=) |
| EP (1) | EP3359567A2 (https=) |
| JP (1) | JP6858182B2 (https=) |
| KR (1) | KR102687412B1 (https=) |
| CN (1) | CN108137682B (https=) |
| AU (1) | AU2016333903B2 (https=) |
| CA (1) | CA3000725A1 (https=) |
| EA (1) | EA201890891A1 (https=) |
| HK (2) | HK1259386A1 (https=) |
| MA (1) | MA50638A (https=) |
| MX (1) | MX2018004170A (https=) |
| WO (1) | WO2017062456A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112016013347B1 (pt) | 2013-12-26 | 2023-12-12 | Mitsubishi Tanabe Pharma Corporation | Anticorpo monoclonal humano neutralizante anti-il-33, composição farmacêutica, inibidor da expressão de citocinas, molécula de ácido nucleico, vetor, célula bacteriana transgênica, método de produção e uso dos mesmos |
| SG11201605580RA (en) | 2014-01-10 | 2016-10-28 | Anaptysbio Inc | Antibodies directed against interleukin-33 (il-33) |
| TWI705976B (zh) | 2014-11-10 | 2020-10-01 | 美商建南德克公司 | 抗介白素-33抗體及其用途 |
| CN107109494B (zh) | 2014-11-10 | 2023-10-27 | 豪夫迈·罗氏有限公司 | Il-33介导型疾病的治疗方法和诊断方法 |
| EA201890891A1 (ru) | 2015-10-06 | 2018-09-28 | Ридженерон Фармасьютикалз, Инк. | Биомаркеры, связанные с заболеваниями, опосредованными интерлейкином-33 (ил-33), и их применение |
| JP2019516362A (ja) | 2016-04-27 | 2019-06-20 | ファイザー・インク | 抗ｉｌ−３３抗体、その組成物、方法および使用 |
| KR102460040B1 (ko) | 2016-04-27 | 2022-11-01 | 애브비 인코포레이티드 | 항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법 |
| ES3052989T3 (en) * | 2017-04-13 | 2026-01-16 | Regeneron Pharma | Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding il33 and il1rl1 |
| CA3066918A1 (en) | 2017-06-12 | 2018-12-20 | Bluefin Biomedicine, Inc. | Anti-il1rap antibodies and antibody drug conjugates |
| MY199245A (en) * | 2017-08-31 | 2023-10-23 | Hyogo College Medicine | Il-33 antagonist-containing therapeutic agent for endometriosis |
| CN109061139A (zh) * | 2018-06-19 | 2018-12-21 | 温州医科大学附属第医院 | 血清炎性生物标志物在防治急性缺血性脑梗死中的应用 |
| TW202519263A (zh) * | 2019-03-21 | 2025-05-16 | 美商再生元醫藥公司 | 含有抗il-33抗體之穩定調配物 |
| US20230099101A1 (en) * | 2020-03-06 | 2023-03-30 | The Regents Of The University Of Michigan | Serine protease inhibitors for suppressing or preventing anaphylactic reaction |
| AU2021236306A1 (en) | 2020-03-13 | 2022-09-15 | Genentech, Inc. | Anti-interleukin-33 antibodies and uses thereof |
| JP7578943B2 (ja) * | 2020-07-13 | 2024-11-07 | 学校法人自治医科大学 | 褥瘡治療剤 |
| CN114814242B (zh) * | 2022-06-10 | 2025-04-01 | 中日友好医院(中日友好临床医学研究所) | 一种诊断慢性阻塞性肺疾病患者肌肉减少症的血液学标志物 |
| EP4658247A1 (en) * | 2023-01-31 | 2025-12-10 | Vivacelle Bio, Inc. | Compositions and methods for treating hyperprocalcitonemia |
| KR102834740B1 (ko) * | 2023-04-10 | 2025-07-17 | 아주대학교산학협력단 | Hsp10 또는 이의 항체를 유효성분으로 포함하는 만성 자발적 두드러기의 진단을 위한 바이오마커 조성물 |
| WO2026007411A1 (zh) * | 2025-02-11 | 2026-01-08 | 广州医科大学 | 抗IL1RL1/IL-33/NF-kB抗体和使用其治疗急性髓性白血病的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4227454C1 (de) * | 1992-08-19 | 1994-02-03 | Henning Berlin Gmbh | Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens |
| NZ549040A (en) * | 2004-02-17 | 2009-07-31 | Schering Corp | Use for interleukin-33 (IL33) and the IL-33 receptor complex |
| WO2010025393A2 (en) * | 2008-08-28 | 2010-03-04 | The Regents Of The University Of California | Protein biomarkers and methods for diagnosing kawasaki disease |
| JO3532B1 (ar) * | 2013-03-13 | 2020-07-05 | Regeneron Pharma | الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها |
| WO2014152195A1 (en) * | 2013-03-15 | 2014-09-25 | Regeneron Pharmaceuticals, Inc. | Il-33 antagonists and uses thereof |
| SG11201603127WA (en) * | 2013-10-23 | 2016-05-30 | Genentech Inc | Methods of diagnosing and treating eosinophilic disorders |
| EA201890891A1 (ru) | 2015-10-06 | 2018-09-28 | Ридженерон Фармасьютикалз, Инк. | Биомаркеры, связанные с заболеваниями, опосредованными интерлейкином-33 (ил-33), и их применение |
-
2016
- 2016-10-05 EA EA201890891A patent/EA201890891A1/ru unknown
- 2016-10-05 KR KR1020187009724A patent/KR102687412B1/ko active Active
- 2016-10-05 AU AU2016333903A patent/AU2016333903B2/en active Active
- 2016-10-05 HK HK19101754.3A patent/HK1259386A1/zh unknown
- 2016-10-05 CN CN201680058610.4A patent/CN108137682B/zh active Active
- 2016-10-05 CA CA3000725A patent/CA3000725A1/en active Pending
- 2016-10-05 EP EP16790463.0A patent/EP3359567A2/en active Pending
- 2016-10-05 WO PCT/US2016/055502 patent/WO2017062456A2/en not_active Ceased
- 2016-10-05 JP JP2018517626A patent/JP6858182B2/ja active Active
- 2016-10-05 HK HK18115046.2A patent/HK1255972A1/zh unknown
- 2016-10-05 MX MX2018004170A patent/MX2018004170A/es unknown
- 2016-10-05 US US15/285,772 patent/US10005834B2/en active Active
- 2016-10-05 MA MA050638A patent/MA50638A/fr unknown
-
2018
- 2018-05-21 US US15/985,660 patent/US10851158B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018533557A5 (https=) | ||
| Fulkerson et al. | Targeting eosinophils in allergy, inflammation and beyond | |
| JP2020513404A5 (https=) | ||
| Izuhara et al. | IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies | |
| RU2731713C2 (ru) | Применение il-18-связывающего белка (il-18bp) при воспалительных заболеваниях | |
| JP6858182B2 (ja) | インターロイキン３３（ｉｌ−３３）媒介疾患に関するバイオマーカーおよびその使用 | |
| JP2016536332A5 (https=) | ||
| CN110167963A (zh) | 治疗发炎病况的方法 | |
| RU2016134838A (ru) | Дипептидил пептидаза-4 (dpp4/cd26) как периферический биомаркер активации il-13 в астматическом легком | |
| Grainge et al. | Targeted therapeutics for severe refractory asthma: monoclonal antibodies | |
| Hernandez‐Santana et al. | Current perspectives on the interleukin‐1 family as targets for inflammatory disease | |
| JP2017509692A5 (https=) | ||
| JP2008502366A5 (https=) | ||
| CN106211782A (zh) | 抗体‑fynomer缀合物 | |
| JP2013047259A (ja) | Ｉｌ−３１アンタゴニストを用いて神経組織における疼痛及び炎症を治療する方法 | |
| HUE034005T2 (en) | Therapies for improving lung function | |
| JP2016529232A (ja) | サイトカインアンタゴニストの標的化 | |
| RU2009120202A (ru) | Способы и композиции для лечения и мониторинга лечения связанных с il-13 расстройств | |
| EP3102601B1 (en) | Novel assay to detect human periostin | |
| KR20240049348A (ko) | 항-인터루킨-33 항체를 사용한 만성 폐쇄성 폐질환의 치료 | |
| CN106397591A (zh) | 骨关节炎治疗 | |
| Mitchell et al. | Anti-IgE and biologic approaches for the treatment of asthma | |
| TWI870471B (zh) | 全身性硬化症治療用醫藥組合物 | |
| AU2023329162A1 (en) | Treatment of asthma with an anti-interleukin-33 antibody | |
| CN108135913A (zh) | 治疗和/或预防特应性皮炎的il-17c拮抗剂 |